ETX0282 Presentations and Publications


Our scientific publications in high-quality journals reflect the quality of the innovative research in Entasis’ laboratories.


Poster Title:  Cefpodoxime proxetil/ETX0282: A novel oral β-lactam/β-lactamase inhibitor combination to treat the emerging threat of multi-drug resistant Enterobacteriaceae
Presented by:  John O’Donnell
Meeting:  ASM Microbe, New Orleans, June 2017

Poster Title:  The Antibacterial Activity of Cefpodoxime and the Novel b-lactamase Inhibitor ETX1317 Against Recent Clinical Isolates of b-lactamase-producing Enterobacteriaceae
Presented by:  Sarah McLeod
Meeting:  ASM Microbe, New Orleans, June 2017

Presentation Title:  ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae
Presented by:  Thomas Durand-Reville
Meeting:  ASM Microbe, New Orleans, June 2017

“Our scientific approach and expertise, coupled with Entasis’ strong pipeline of programs, really make us stand out in the field of antibacterial drug discovery and development.”

— Satenig Guler, Senrio Scientist